CKD Bio Corp.

Informe acción KOSE:A063160

Capitalización de mercado: ₩131.1b

CKD Bio Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Hui Kang

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

What You Need To Know About CKD Bio Corp.'s (KRX:063160) Investor Composition

Feb 28
What You Need To Know About CKD Bio Corp.'s (KRX:063160) Investor Composition

Is CKD Bio's (KRX:063160) 203% Share Price Increase Well Justified?

Feb 01
Is CKD Bio's (KRX:063160) 203% Share Price Increase Well Justified?

CKD Bio (KRX:063160) Takes On Some Risk With Its Use Of Debt

Jan 11
CKD Bio (KRX:063160) Takes On Some Risk With Its Use Of Debt

What CKD Bio Corp.'s (KRX:063160) ROE Can Tell Us

Dec 21
What CKD Bio Corp.'s (KRX:063160) ROE Can Tell Us

Here's Why We Don't Think CKD Bio's (KRX:063160) Statutory Earnings Reflect Its Underlying Earnings Potential

Nov 30
Here's Why We Don't Think CKD Bio's (KRX:063160) Statutory Earnings Reflect Its Underlying Earnings Potential

CEO

Hui Kang

no data

Permanencia

Mr. Hui Yil Kang serves as a Co-Chief Executive Officer, Vice President, and Director of Ckd Bio Corporation.